title: What action should be taken to prevent spread of vancomycin resistant enterococci in European hospitals?
authors.affiliation: Eijkman-Winkler Institute for Microbiology, Infectious Diseases, and Inflammation, Division of Hospital Hygiene and Infection Prevention, University Medical Centre Utrecht, Heidelberglaan 100, 3584 CX Utrecht, Netherlands. m.j.m.bonten@azu.nl
authors.forename: Ben
authors.initials: B
authors.lastname: Ridwan
authors.forename: Ellen
authors.initials: E
authors.lastname: Mascini
authors.forename: Netty
authors.initials: N
authors.lastname: van Der Reijden
authors.forename: Jan
authors.initials: J
authors.lastname: Verhoef
authors.forename: Marc
authors.initials: M
authors.lastname: Bonten
mesh_terms: D003428:Cross Infection / Q000453:epidemiology / Q000517:prevention & control*; D004196:Disease Outbreaks; D004352:Drug Resistance, Microbial; D016983:Enterococcus / Q000187:drug effects*; D006801:Humans; D017053:Infection Control / Q000191:economics / Q000379:methods; D009426:Netherlands / Q000453:epidemiology; D013290:Streptococcal Infections / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control; D014640:Vancomycin / Q000627:therapeutic use*
chemical_list: D014640:Vancomycin